🇺🇸 FDA
Patent

US 6017524

Inhibiting the growth p53 deficient tumor cells by administering the p53 gene

expired A61KA61K38/00A61K38/1709

Quick answer

US patent 6017524 (Inhibiting the growth p53 deficient tumor cells by administering the p53 gene) held by The Board of Regents of the University of Texas System expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
41
CPC classes
A61K, A61K38/00, A61K38/1709, A61K48/00